Bone Marrow TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationHematopoietic Stem CellsGraft vs Host DiseaseTransplantation ConditioningTransplantation, AutologousStem CellsBone MarrowBone Marrow CellsHematologic NeoplasmsTransplantation ChimeraPeripheral Blood Stem Cell TransplantationTissue DonorsBusulfanWhole-Body IrradiationGraft SurvivalLeukemiaTreatment OutcomeHistocompatibility TestingRecurrenceGraft vs Leukemia EffectRemission InductionLiver TransplantationMyeloablative AgonistsGraft vs Tumor EffectAnemia, AplasticLeukemia, Myeloid, AcuteHematopoiesisHistocompatibilityLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressive AgentsCombined Modality TherapyVidarabineLymphocyte TransfusionHematopoietic Stem Cell MobilizationRetrospective StudiesCord Blood Stem Cell TransplantationAntigens, CD34CyclophosphamideMyelodysplastic SyndromesLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaMultiple MyelomaCell DifferentiationTime FactorsCytomegalovirus InfectionsSurvival AnalysisHepatic Veno-Occlusive DiseaseMice, Inbred C57BLDisease-Free SurvivalSurvival RateChimerismKidney TransplantationEmbryonic Stem CellsSiblingsT-LymphocytesMesenchymal Stem Cell TransplantationTransplantation, IsogeneicSalvage TherapyMinor Histocompatibility AntigensAntilymphocyte SerumBone and BonesAcute DiseaseAdult Stem CellsMelphalanHematologic DiseasesHLA AntigensTransplantation ImmunologyNeoplasm, ResidualFlow CytometryAntineoplastic Combined Chemotherapy ProtocolsLeukemia, MyeloidCell LineageStem Cell NicheColony-Forming Units AssayImmunosuppressionBone Marrow PurgingCell TransplantationGraft RejectionGranulocyte Colony-Stimulating FactorFollow-Up StudiesCells, CulturedVirus ActivationLymphoma, Non-HodgkinRadiation ChimeraCytarabinePrimary MyelofibrosisCytomegalovirusPrognosisLeukocyte TransfusionHeart TransplantationNuclear FamilyPluripotent Stem CellsCell SeparationCyclosporineMesenchymal Stromal CellsImmunocompromised HostLymphoproliferative Disorders